Top Page
Abacus Life
(NASDAQ:ABL)
Abacus Life (ABL) vs. SPDR S&P 500 ETF (SPY)
Abacus Life Business Overview & Revenue Model
Abacus Life Earnings Call Summary
Abacus Life Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.43M | 111.92M | 66.40M | 44.71M | 22.59M | 27.37M |
| Gross Profit | 117.92M | 100.55M | 59.91M | 38.83M | 8.39M | 26.86M |
| EBITDA | 23.45M | 12.72M | 23.33M | 34.81M | 1.03M | 0.00 |
| Net Income | -17.97M | -23.96M | 9.52M | 31.68M | 997.41K | 1.44M |
Balance Sheet | ||||||
| Total Assets | 856.51M | 874.16M | 331.83M | 59.09M | 5.29M | 3.74M |
| Cash, Cash Equivalents and Short-Term Investments | 43.76M | 131.94M | 27.84M | 30.05M | 2.60M | 1.85M |
| Total Debt | 123.07M | 385.91M | 141.74M | 28.33M | 367.51K | 65.61K |
| Total Liabilities | 420.93M | 450.87M | 167.76M | 30.95M | 2.57M | 1.13M |
| Stockholders Equity | 435.68M | 424.15M | 163.93M | 27.25M | 80.00K | 2.08M |
Cash Flow | ||||||
| Free Cash Flow | -273.46M | -209.62M | -64.71M | 10.61M | 1.12M | 904.09K |
| Operating Cash Flow | -273.46M | -211.01M | -64.52M | 10.69M | 1.34M | 904.09K |
| Investing Cash Flow | -8.69M | -4.96M | 2.24M | -3.70M | -241.53K | 16.40K |
| Financing Cash Flow | 259.73M | 320.12M | 57.82M | 22.96M | -354.58K | -329.10K |
Abacus Life Technical Analysis
Abacus Life Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $3.26B | 15.89 | 2.73% | ― | 0.98% | 156.14% | |
67 Neutral | $16.86B | 11.64 | 9.71% | 3.83% | 11.61% | -9.60% | |
62 Neutral | $3.84B | 13.53 | 12.47% | 1.76% | -0.78% | -16.22% | |
59 Neutral | $181.04M | 20.87 | 4.23% | ― | 1.80% | -39.04% | |
53 Neutral | $48.34M | ― | -1.43% | 0.94% | 2.04% | -66.36% | |
49 Neutral | $3.09B | 6.43 | 13.00% | ― | 14.74% | ― | |
48 Neutral | $518.70M | ― | -5.98% | ― | 76.25% | -924.20% |
Abacus Life Corporate Events
On June 30, 2025, Abacus Global Management announced the commencement of an exchange offer and consent solicitation related to its outstanding public and private placement warrants. The company aims to simplify its capital structure and reduce the potential dilutive impact of the warrants by offering 0.23 shares of common stock in exchange for each warrant tendered. If successful, this move could increase the company’s flexibility for future financing and potentially result in an increase of approximately 5% in the total outstanding shares of common stock. The offer and consent solicitation are set to expire on July 29, 2025, and require the consent of at least 50% of the public warrant holders to amend the warrant agreement.
The most recent analyst rating on (ABL) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.
On June 27, 2025, Abacus Global Management, Inc. announced its plan to conduct a registered exchange offer and consent solicitation for its outstanding public and private placement warrants. The company intends to offer holders 0.23 shares of common stock for each warrant exchanged, while also seeking consent to amend the Warrant Agreement to allow a mandatory exchange at a slightly lower ratio. This move aims to streamline the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (ABL) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.
On June 12, 2025, Abacus Global Management, Inc. held its 2025 Annual Meeting of Stockholders where key decisions were made regarding the company’s governance and financial oversight. The meeting resulted in the re-election of Cornelis Michiel van Katwijk, Mary Beth Schulte, and Karla Radka as Class II directors for a three-year term, and the ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (ABL) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.
On May 8, 2025, Abacus Global Management, Inc. announced salary adjustments and compensation changes for its executive team, including the CEO, CFO, and Presidents. The changes involve increased annual salaries, performance-based restricted stock units (RSUs), and annual cash bonuses tied to the company’s 2025 performance targets. The RSUs will vest based on the company’s adjusted net income performance, with a stretch target set at $140 million. Additionally, the CEO is eligible for a one-time equity bonus if certain market capitalization targets are achieved.
The most recent analyst rating on (ABL) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.
On April 9, 2025, Abacus Global Management, Inc. announced that its Board of Directors approved a $15 million stock repurchase program, which will be in effect for eighteen months. This strategic move is expected to impact the company’s operations by potentially increasing shareholder value and improving market positioning.
On March 27, 2025, Abacus Global Management, Inc.’s Compensation Committee revised the vesting terms for restricted stock units (RSUs) granted to employees under the 2023 Long-Term Equity Compensation Incentive Plan. The changes affect 500,000 RSUs granted to the CFO, William H. McCauley, Jr., with the revised terms allowing one-third of the RSUs to vest and convert to common stock or cash on July 3 of 2024, 2025, and 2026.